11. |
DoxylamineA Cause for False‐Positive Gas Chromatographic Assay for Phencyclidine |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 181-184
John Schaldenbrand,
Kenneth McClatchey,
Jayant Patel,
Merry Muilenberg,
Preview
|
PDF (173KB)
|
|
摘要:
A 25-year-old white woman ingested an unknown quantity of doxylamine succinate and flurazepam. Urine immunoassay screen (EMIT-dau®) was positive for benzodiazopine and negative for phencyclidine. Subsequent gas chromatographic assay of the urine revealed a markedly positive assay for phencyclidine. Doxylamine was ultimately found to be the cause for the false-positive gas chromatographic assay for phencyclidine.
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
12. |
Adaptation of EMIT® Procedures for Maximum Cost Effectiveness to Two Different Centrifugal Analyzer Systems |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 185-192
William Shaw,
Jerry McHan,
Preview
|
PDF (475KB)
|
|
摘要:
We have adapted commercial immunoassay (EMIT®) procedures for dilantin, phenobarbital, theophylline, carbamazepine, tobramycin, disopyramide, quinidine, procainamide,N-acetyl procainamide, and mysoline to two different centrifugal analyzers (Centrifichem and Multistat) using maximum dilutions of reagents to reduce reagent costs to approximately one-tenth of that incurred using the manufacturer's protocol. This savings due to the dilutions of reagents was primarily because of the ability to prolong the reaction time to achieve acceptably large absorbance changes over the absorbance measurement period. Correlation coefficients between values for drugs analyzed by these modified EMIT protocols and values obtained by other methods ranged from 0.927 to 0.994. Within-run precision and recovery values for these drugs were also entirely acceptable. We found that premature mixing of reagents in the rotors of the Multistat system and variable delivery of reagent in the Centrifichem 400 system were both caused by the surfactant in the EMIT buffer. The former problem is being resolved by the manufacturer; the latter problem was resolved by siliconizing the reagent pipet tips.
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
13. |
Letter |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 193-202
Jerome Lewis,
Preview
|
PDF (53KB)
|
|
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
14. |
Brain Dysfunction in ChildrenEtiology, Diagnosis and Management |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 203-203
Michael Kirschner,
Preview
|
PDF (88KB)
|
|
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
15. |
Phenytoin‐Induced Teratology and Gingival Pathology |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 204-206
Paul Kamen,
Preview
|
PDF (204KB)
|
|
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
16. |
Clinical Drug AnalysisTechniques and Interpretation |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 207-207
&NA;,
Preview
|
PDF (40KB)
|
|
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|
17. |
Bibliography of Recent Literature in Therapeutic Drug MonitoringCitations Retrieved from Medlars II, National Interactive Retrieval Service, National Library of Medicine |
|
Therapeutic Drug Monitoring,
Volume 3,
Issue 2,
1981,
Page 208-208
Preview
|
PDF (846KB)
|
|
ISSN:0163-4356
出版商:OVID
年代:1981
数据来源: OVID
|